Skip to content

Role of Concentration of Biomarkers S100B and NSE in Serum in Mild and Moderate Head Trauma

Role of Concentration of Biomarkers S100B and NSE in Serum in Mild and Moderate Head Trauma Injury in Acute Phase in Relation to Head CT and Post Concusion Syndrome.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02988102
Enrollment
70
Registered
2016-12-09
Start date
2016-12-31
Completion date
2017-08-31
Last updated
2016-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biomarkers

Keywords

S100B, NSE, moderate brain trauma, mild brain trauma

Brief summary

In pediatric age groups communication difficulties very sometimes may present further obstacles in obtaining a detailed injury history and early identification of TBI symptoms. Most emergency management protocols are focused exclusively on the identification of the relatively small number of patients who may require operative intervention, as early surgery is believed to improve outcome.

Detailed description

However early rehabilitation can also be effective for the much larger number of patients who do not require surgery\[1\] In addition, Hall and others recently reported that low doses of ionizing radiation to the brain in infancy may influence cognitive abilities in adulthood. \[2\] Accordingly, increased serum concentrations of, for example S100B ( a calcium-binding protein present in high concentrations in glial cells) and neurone-specific enolase ( NSE: a cytoplasmatic enzyme occuring predominantly in neurones ) have been demonstrated to reflect the presence and severity of brain tissue damage in acute head injuries. \[3\] In both pediatric age and adults.

Interventions

OTHERFollowing S100B and NSE in head trauma

Following S100B and NSE in head trauma in correlation with Head CT and post concussion syndrome and Lisat11

Sponsors

University Clinical Centre of Kosova
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Only head trauma without any other body injury

Exclusion criteria

* Blood thinner, hydrocephalus , previous brain infarcts, encephalopathy, birth trauma.

Design outcomes

Primary

MeasureTime frame
Role of concentration of biomarkers S100B and NSE in serum in mild and moderate head trauma injury in acute phase in relation to head CT and post concusion syndrome.2 years

Countries

Albania

Contacts

Primary ContactFatos Kelmendi
dr.kelmendifatos@gmail.com+377 44 128 255
Backup ContactAgon Mekaj, PhD
dragonmekaj@gmail.com+377 44 373545

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026